Product Details


In-depth analysis of COVID-19 impacting on Squalene Market by Source Type (Animal Source (Shark Liver Oil), Vegetable Source (Olive Oil, Palm Oil, Amaranth Oil), Biosynthetic (GM Yeast]), End-use Industry (Cosmetics, Food, and Pharmaceuticals), and Region- Global Forecast to 2025

Get in-depth analysis of how COVID-19 is impacting the Squalene Market. We’ve been tracking the direct impact of COVID-19 on Squalene Market, as well as the indirect impact from other industries. The report will incorporate these insights.

The Squalene Market, in terms of value, is projected to grow at a CAGR of XX% from 2020 to 2025. The market is estimated to be USD XX Million in 2020, and is projected to reach XX Million by 2025. In this study, 2019 has been considered the base year, and 2020 to 2025 the forecast period, for estimating the market size of the global market.

The scope of the study is global. GMR Research analyzes each market and its application, new products and advancements, market projections and market shares. This study surveys each market in all the geographic regions including North America, Europe and emerging markets. GMR Research analyzes the current market situation by discussing the market drivers, restraints, challenges and opportunities. The latest news pieces including new products, mergers and acquisitions in each market are also dealt with in sufficient detail. Also included in the report are relevant patent analysis and comprehensive profiles of companies that are dominant in the Squalene industry. The key market players profiled in the report include as Sophim (France), Amyris (US), Arista Industries Inc. (US), SeaDragon Marine Oils Limited (New Zealand), Nucelis LLC (US), Ekiz Olive Oil & Soap Inc. (Turkey), Kishimoto Special Liver Oil Co. Ltd. (Japan), Empresa Figueirense De Pesca, Lda (Portugal), Arbee BiomarineExtracts Pvt. Ltd. (India), and New Zealand GreenHealth Limited (New Zealand).

Impact of COVID-19 on Squalene Market: The countries, including Italy, France, Germany, and Spain, are highly affected by the COVID-19 pandemic. Hence, the negative growth is expected in the personal care industry, which will decline the demand for squalene in 2020. Due to the lockdown in majority of countries in Europe the sales of beauty products in retail sector has declined tremendously. In Europe the demand for luxury beauty products is very high, due to the closure of retail sector the demand for squalene has declined in Europe. The leading cosmetics manufacturer L’Oréal (France) has announced decline in revenue of about 5% for the first quarter of 2020. According to L’Oréal (France) its strong e-commerce network across the globe is expected to grow its sales in 2021.
Beneficial properties of squalene for human health

Squalene is a natural skin ingredient as it is naturally present in the skin in minute concentrations. It has many beneficial properties such as anti-oxidation, anti-aging, UV protection, and others, thus finding applications in the cosmetic, pharmaceutical, and food industries. Squalene is not easily influenced by peroxidation, and appears to function as a quencher of singlet oxygen in the skin and, therefore, protects human skin surface from the exposure of ultraviolet light and other sources of oxidative damage. It acts as a detoxifier for highly lipophilic xenobiotics, assisting with their elimination from the body. Therefore, it does not have side effects in comparison to other drugs, which is why it is used in pharmaceutical formulations to reduce the dosage of drugs and the side effects. Squalene is used along with common cancer drugs for the treatment of leukemia and other cancers; for preventing radiation illness from cancer X-ray therapy; and for treating common cold, flu, and swine flu. It also aids in the body’s immune system and is used for increasing white cells count during treatment with anti-cancer drugs. The demand for squalene is increasing in the food, cosmetic, and pharmaceutical industries due to its low ill effects on human skin and internal organs.

Growth in pharmaceutical and cosmetic industries

The growth in the pharmaceutical industry is expected to be a major driver for squalene demand in the future. Increasing R&D in the oncology segment, along with increasing spending on oncology medicines, is expected to drive the market. The global pharmaceuticals sales was around USD 1000 billion in 2019, and it is expected to further grow with 6-7% during the forecast period. An additional sale of pharmaceuticals from orphan drugs is expected by 2025. The future spending on oncology medicines in the next five years is expected to be in the range of 6.0–8.0%, which is likely to boost the squalene market. In addition, the rising cosmetic industry in emerging markets such as Brazil, China, and India; increasing consumer awareness about the usage of high-quality cosmetic products; and willingness to pay premium prices are driving the cosmetic industry at the global level. Therefore, squalene has wide usage in this industry.

Consumer skepticism about animal-sourced products and limitations on shark fishing

Squalene is majorly derived from shark liver oil, leading to overfishing of sharks. The consumer skepticism regarding the usage of animal-sourced products has led the end-use manufacturers to avoid using squalene sourced from shark liver in their products. Most laws allow shark liver oil to be extracted as a by-product of shark fishing. With the reduction in shark fishing activities due to certain rules and regulations and overfishing of sharks, the supply of shark livers has decreased, which is affecting the supply of squalene. Several regulatory agencies such as General Fisheries Commission of the Mediterranean (GFCM), North East Atlantic Fisheries Commission (NEAFC), Commission for Conservation of Antarctic Marine Living Resources (CCAMLR), and North Atlantic Fisheries Organization (NAFO) have imposed limitations such as fixed quotas for shark fishing, which, in turn, has resulted in supply shortage of shark liver and, thereby squalene.
New renewable sources for squalene production

With skepticism about the shark liver oil sourced from sharks and low concentration of squalene in vegetable oils, the supply is fluctuating, and the prices are volatile. As several regulations are introduced for shark fishing, the supply of squalene has been majorly affected. In the vegetable oils, squalene content is very low, and therefore, tons of olives and amaranth are required to produce a small quantity of squalene. Collectively, these reasons have led to high squalene retail prices. This sparks an opportunity for the players to come up with new technologies to develop squalene and squalane from alternative sources.

Sugarcane and other sugar-containing bio-materials have been identified as the sources for producing squalane (hydrogenated squalene). This is expected to increase the supply of raw materials for squalene production. Squalane is actively researched by pharmaceutical companies such as Novartis AG (Switzerland) and GlaxoSmith Kline (UK) for applications in their formulations. The pharmaceutical sector is currently trying to reduce the side effects of their products by incorporating squalane in their formulations. For instance, Amyris, a US-based biotechnology company, has developed the technology to directly produce squalane through the process of yeast fermentation from sugarcane. SynShark is also working with scientists at Texas A&M University (US) to produce squalene from tobacco crops. These tobacco crops are the special plants from which squalene can be synthesized directly from the tobacco leaves. The commercial viability of these innovations would attract more players in the market. This is expected to bring along more competitiveness into the market in terms of pricing and supply, thereby benefitting the end users.


The main objective of the report is to define, describe, and forecast the global Squalene market. The report provides detailed information regarding the major factors influencing the growth of the predictive analytics market (drivers, restraints, opportunities, and industry-specific challenges).

The report aims to strategically analyze micro markets with respect to the individual growth trends, prospects, and contributions to the total market. The report attempts to forecast the market size with respect to the 5 main regions, namely, North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America. The report strategically profiles key players and comprehensively analyzes their core competencies. It also tracks and analyzes competitive developments, such as partnerships, collaborations, and agreements; mergers and acquisitions; new product launches and new product developments; and Research and Development (R&D) activities in the market.

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as dietary supplement manufacturers, distributors and dealers, customers and policy makers. The study would help them to identify which market segments should be targeted over the coming years in order to strategize investments and capitalize on the growth opportunities in the market.

Scope of the Report:

On the basis of source type, the squalene market has been segmented as follows:

  • Animal Source
  • Vegetable Source
  • Biosynthetic

On the basis of end-use industry, the squalene market has been segmented as follows:

  • Cosmetics
  • Food
  • Pharmaceuticals
  • Others

On the basis of Region, the squalene market has been segmented as follows:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
    4.1 Significant Opportunities in the Squalene Market
    4.2 Squalene Market, By Source Type
    4.3 Squalene Market, By End-Use Industry
    4.4 Squalene Market, By Region

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
           Beneficial Properties Of Squalene For Human Health
           Growth In Pharmaceutical And Cosmetic Industries
           5.2.2 Restraints
           Consumer Skepticism About Animal-Sourced Products And Limitations On Shark Fishing
           Volatile Supply Of Raw Materials
           5.2.3 Opportunities
           New Renewable Sources For Squalene Production

6 Squalene Market, By Source Type
    6.1 Introduction
    6.2 Animal Source
    6.3 Vegetable Source
    6.4 Biosynthetic

7 Squalene Market, By End-Use Industry
    7.1 Introduction
    7.2 Cosmetic
    7.3 Food
    7.4 Pharmaceutical
    7.5 Others

8 Squalene Market, By Region
    8.1 Introduction
    8.2 Europe
    8.3 APAC
    8.4 North America
    8.5 Middle East & Africa
    8.6 South America

9 Competitive Landscape

10 Company Profiles
     (Business Overview, Products Offered, Financials, Recent Developments, SWOT Analysis)*
     10.1 Seadragon Marine Oils Limited
     10.2 Amyris
     10.3 Arbee Biomarine Extracts Pvt. Ltd.
     10.4 Sophim
     10.5 Kishimoto Special Liver Oil Co. Ltd.
     10.6 Empresa Figueirense De Pesca, LDA
     10.7 Nucelis LLC
     10.8 Arista Industries
     10.9 Ekiz Olive Oil & Soap Inc.
     10.10 New Zealand Green Health Ltd.
     10.11 RLR Squalene
     10.12 Cabomer Inc.
     10.13 Blueline Foods Pvt. Ltd.
     10.14 Coastal Aquatic Proteins
     10.15 Globalab
     10.16 Squalop
     10.17 CN Lab Nutrition
     10.18 Isho Genki International
*Details Might Not Be Captured in Case of Unlisted Companies.

Single User   1530.00

Multiple User   2200.00
Latest Product